MyAverix Finance
AT · Healthcare
Lavipharm S.A (LAVI)
Drug Manufacturers - Specialty & Generic
Lavipharm S.A (LAVI) is listed on AT in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LAVI
Lavipharm S.A (LAVI) — FAQ
What is LAVI's P/E ratio?
The price-to-earnings (P/E) ratio for Lavipharm S.A (LAVI) is 18.00 (data as of 2026-03-22).
Does Lavipharm S.A pay a dividend?
Dividend yield is not available in the current snapshot for Lavipharm S.A (LAVI). Check the MyAverix Finance app for the latest dividend data.
What sector is Lavipharm S.A in?
Lavipharm S.A (LAVI) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is LAVI listed on?
LAVI is listed on AT.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.